EFPIA Newsletter 21 October 2021

Blogs     15 October 2021 The future of healthcare is systematic digitization and unification of data Takeaways from The Value of Innovation conference Read more →

Making the impossible, possible

	Boehringer Ingelheim Treatments once known for T2 diabetes are now making it possible to prevent heart failure, stroke and kidney disease, allowing people to live longer, better lives.		Menarini Novel therapeutics are making recovering from blood cancers like BPDCN possible and could make it possible to treat other rare blood cancers too.

Events     08 NOV 2021   Global Pharmaceutical and Biotechnology Conference Virtual event Sustaining innovation and collaboration beyond the pandemic #FTPharma Learn more →       26 OCT 2021   “Masterclass” Scaling Innovations Emerging from Public-Private Partnerships Virtual event The Innovative Medicines Initiative is delighted to invite you to this virtual event. Learn more →

	09 NOV 2021			Investigating the syndemic threat of COVID-19 and chronic disease: The diabetes case... Virtual event Improved integration of care is the way forward to strengthen chronic disease management in emergencies and beyond Learn more →

	16 NOV 2021			Pandemic Prevention: how Europe can lead the fight against AMR Virtual event The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. Learn more →

What we are reading Innovative Health Initiative reaches new milestone 21 October 2021  (EUHealthPPP) Read more → EFPIA On Why More EU Drug Price Transparency Isn’t The Answer 15 October 2021  (Pink Sheet - paywall) Read more → How France overcame vaccine hesitancy - and where Romania went wrong 08 September 2021  (Vaccines Today) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe